Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)

Mayo Clinic100 enrolled

Overview

This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Bladder Urothelial Carcinoma

Interventions

Non-Interventional StudyOTHER

Non-interventional study

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Undergoing radical cystectomy for confirmed or suspected urothelial carcinoma of the bladder * Prior abdominal imaging Exclusion Criteria: * History of partial cystectomy or complex bladder reconstruction or substitution (i.e. bladder augment or urothelial recurrence in a neobladder)

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

RECRUITING

Outcomes

Primary Outcomes

Concordance between US and core needle biopsy stage and final surgical specimen pathologic stage

The radiology-assessed tumor stage from the ultrasound (US) and the core needle biopsy-assessed tumor stage will be compared with the final pathologic tumor stage.

Time frame: Baseline (after completion of bladder surgery)

Central Contacts

Hosanna Yeadon, BA

CONTACT

507-538-5019 biffert.hosanna@mayo.edu

Clinical Trials Referral Office

CONTACT

855-776-0015 mayocliniccancerstudies@mayo.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.